Advanced search
Publication Cover
Acta Oncologica Volume 43, 2004 - Issue 6
Journal homepage
213
Views
8
CrossRef citations to date
0
Altmetric
Letter to the Editor

Erythropoietin enhances response to treatment in patients with advanced breast cancer

Anna-Maria Larsson
,
Göran Landberg
,
Sven Påhlman
&
Maria AlbertssonCorrespondence[email protected]
Pages 594-597 | Received 16 Mar 2004, Accepted 04 Jun 2004, Published online: 08 Jul 2009

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Krystyna Serkies, Andrzej Badzio & Jacek Jassem. (2006) Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy. Acta Oncologica 45:6, pages 695-701.
Read now
Christian Peters-Engl, Pia Cassik, Irene Schmidt, Ursula Denison, Michael Medl, Wolfgang Pokieser & Paul Sevelda. (2005) Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer. Acta Oncologica 44:2, pages 129-133.
Read now

Articles from other publishers (6)

Anna-Maria Larsson, Karin Jirström, Erik Fredlund, Sofie Nilsson, Lisa Rydén, Göran Landberg & Sven Påhlman. (2009) Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer. Clinical Cancer Research 15:17, pages 5552-5559.
Crossref
Kyoung-Han Kim, Gavin Y. Oudit & Peter H. Backx. (2008) Erythropoietin Protects against Doxorubicin-Induced Cardiomyopathy via a Phosphatidylinositol 3-Kinase-Dependent Pathway. Journal of Pharmacology and Experimental Therapeutics 324:1, pages 160-169.
Crossref
M. R. Nowrousian. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology 449 508 .
David A. Gewirtz, Xu Di, Teneille D. Walker & Stephen T. Sawyer. (2006) Erythropoietin Fails to Interfere with the Antiproliferative and Cytotoxic Effects of Antitumor Drugs. Clinical Cancer Research 12:7, pages 2232-2238.
Crossref
Heinz Ludwig. (2006) Epoetin beta in oncology: examining the current evidence. Future Oncology 2:1, pages 21-38.
Crossref
Peter Vaupel, Jürgen Dunst, Andreas Engert, Joachim Fandrey, Petra Feyer, Mathias Freund & Wolfgang Jelkmann. (2005) Effects of Recombinant Human Erythropoietin (rHuEPO) on Tumor Control in Patients with Cancer-Induced Anemia. Oncology Research and Treatment 28:4, pages 216-221.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.